SAN DIEGO, March 12, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
